Artificial Intelligence (IA)

in
Pharmacovigilance
Monitoring Solution
Before we
begin

AI capabilities of Pharmacovigilance Advisor

 Artificial Intelligence (IA) in
Pharmacovigilance Monitoring

Pharmacovigilance
Market Ø
Ø
Adverse Drug Reaction (ADR)
Adverse Effect (AE)
Opportunity Ø
Ø
Monitoring
Regulatory Compliance
Ø Channels
Ø Challenges

Technology Evolution
Ø Artificial Intelligence (IA)
Ø Natural Language Processing
Ø Big Data
Ø Cloud technologies
Ø Opportunities
 Vison
Transform the way Pharmaceutical research and
healthcare is done

Pharma
Pvt. Ltd.
Founded in 2018 3 founders
Global Leaders from Multination
Pharma Organization

We offer bespoke innovation management services

to healthcare organizations. We bring our domain expertise to
offer customized, fit-for-purpose solutions.

Our Services:

Projects Events Training

 Meet the Humanoid representation of AI
capabilities of Pharmacovigilance Advisor
(credit Accenture).

Solution opens lots of new

opportunities:

Solution • AI will allow us to automate many

repetitive tasks
• Free resources to focus on more
complex inquiries or other value-
added functions
• With restricting budgets and
*Image used only for representation purpose
limited resources, it is easy to
understand why so many
companies are starting to
seriously look at AI.
 Business Model for Artificial Intelligence (IA) in
Pharmacovigilance Monitoring Solution
• AI is not new to Pharma
• The survey conducted by Oracle - three key
insights.
Business • AI - 62% are actively implementing or planning to
Model and implement AI in multiple departments
• Cloud - 58% either have some or all of safety solutions in
Opportunity the cloud or planning to move in the next 2 years
• Regulatory requirement - 63% of respondents
upgrading their systems at least three years to maintain
compliance.

Ultimately the effectiveness of AI can only be

realized by combining the technology with deep
pharmacovigilance expertise and historical data.
 “Pharam Pvt. Ltd. is equipped with its core
pharmaceutical expertise and a wide network to bridge
this gap with our effective execution framework”

Execution
Why Invest? Excellence
The DART Model

Investors should expect :

ROI 1. Breakeven in 3 years
2. 20% year on year growth in Revenue
3. 25% Profit
Q &A ?
Thanks
CONTACT
XXXX XXX XXX